Characterization of focal liver lesions: Comparison of pulse-inversion harmonic contrast-enhanced sonography with contrast-enhanced CT

Journal of Clinical Ultrasound

Volumn 35, Issue 3, 2007, Pages 109-117

  Li, Rui ^a   Guo, Yanli ^a   Hua, Xing ^a   He, Yun ^a   Ding, Jun ^a   Guo, Aiming ^a   Luo, Mingkui ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Computed tomography; Contrast media; Liver; Neoplasms; Ultrasonography

Indexed keywords

ADENOMA; ADULT; AGED; ANGIOMYOLIPOMA; ARTICLE; BILE DUCT CARCINOMA; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; FEMALE; HEMANGIOMA; HISTOPATHOLOGY; HUMAN; LIVER CELL CARCINOMA; LIVER DISEASE; LIVER INJURY; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; NODULAR HYPERPLASIA; STANDARDIZATION; STATISTICAL ANALYSIS;

ADENOMA, LIVER CELL; ADOLESCENT; ADULT; AGED; ANGIOMYOLIPOMA; CARCINOMA, HEPATOCELLULAR; CHOLANGIOCARCINOMA; CONTRAST MEDIA; DIAGNOSTIC ERRORS; FEMALE; FOCAL NODULAR HYPERPLASIA; HEMANGIOMA; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IOHEXOL; LIVER NEOPLASMS; MALE; MIDDLE AGED; NECROSIS; PHOSPHOLIPIDS; PROSPECTIVE STUDIES; RESEARCH DESIGN; SULFUR HEXAFLUORIDE; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY, DOPPLER, COLOR;

EID: 34247846346     PISSN: 00912751     EISSN: 10970096     Source Type: Journal    
DOI: 10.1002/jcu.20310     Document Type: Article

References (21)

1. Folkman J. Role of angiogenesis in tumor growth and metastasis. Semin Oncol 2002;29:15.
2. Bezy-Wendling J, Kretowski M, Rolland Y. Hepatic tumor enhancement in computed tomography: combined models of liver perfusion and dynamic imaging. Comput Bio Med 2003;33:77.
3. Nino-Murcia M, Olcott EW, Jeffrey RB, et al. Focal liver lesions: pattern-based classification scheme for enhancement at arterial phase. Radiology 2000;215:746.
4. World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects. Available at: www.wma.net/e/policy/ pdf/17c.pdf, accessed December 8, 2003.
5. Quaia E, Calliada F, Bertolotto M, et al. Characterization of focal liver lesions with contrast specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence: Radiology 2004;232:420.
6. Dietrich CF. Characterization of focal liver lesions with contrast enhanced ultrasonography. Eur J Radiol 2004;51 (Suppl 1):S9.
7. Rode A, Bancel B, Douek P, et al. Small nodule detection in cirrhotic livers: evaluation with US, spiral CT, and MRI and correlation with pathologic examination of explanted liver. J Comput Assist Tomogr 2001;25:327.
8. Bennett GL, Krinsky GA, Abitbol RJ, et al. Sonographic detection of hepatocellular carcinoma and dysplastic nodules in cirrhosis correlation of pretransplantation sonography and liver explant pathology in 200 patients. AJR Am J Roentgenol 2002;179:75.
9. Teefey A, Hildeboldt CC, Dehdashti F, et al. Detection of primary hepatic malignancy in liver transplant candidates: prospective comparison of CT, MR imaging, US and PET. Radiology 2003;226:533.
10. Kim AY, Choi BI, Kim TK, et al. Hepatocellular carinoma: power Doppler US with a contrast agent-preliminary results. Radiology 1998;209:135.
11. Cedrone A, Pompili M, Sallustio G, et al. Comparison between color power Doppler ultrasound with echo-enhancer and spiral computed tomography in the evaluation of hepatocellular carcinoma vascularization before and after ablation procedures. Am J Gastroenterol 2001;96:1854.
12. Dietrich CF, Ignee A, Trojan J, et al. Improved characterisation of histologically prove tumors by contrast enhanced ultrasonography during the portal venous and specific late phase of SHU 508A. Gut 2004;53:401.
13. Bryant TH, Blomley MJ, Albrecht T, et al. Improved characterization of liver lesions with liver-phase uptake of liver-specific microbubbles: prospective multicenter study. Radiology 2004;232:799.
14. Isozaki T, Numata K, Kiba T, et al. Differential diagnosis of hepatic tumors by using contrast enhancement patterns at US. Radiology 2003;229:798.
15. Solbiati L, Goldberg SN, Lerace T, et al. Radio frequency ablation of hepatic metastases: post procedural assessment with a US microbubble contrast agent-early experience. Radiology 1999;211:643.
16. Morel DR, Schwieger I, Hohn L, et al. Human pharmacokinetics and safety evaluation of Sonovue, a new contrast agent for ultrasound imaging. Invest Radiology 2000;35:80.
17. Herbay AV, Vogt C, Willers R, et al. Real-time imaging with the sonographic contrast agent Sono Vue. J Ultrasound Med 2004;23:1557.
18. Nicolau C, Catala V, Vilana R, et al. Evaluation of hepatocellular carcinoma using Sono Vue, a second generation ultrasound contrast agent: correlation with cellular differentiation. Eur Radiol 2004;14:1092.
19. Longchampt E, Patriarche C, Fabre M. Accuracy of cytology vs microbiopsy for the diagnosis of well-differentiated hepatocellular carcinoma and macroregenerative nodule: definition of standardized criteria from a study of 100 cases. Acta Cytol 2000;44:515.
20. Krix M, Kiessling F, Essig M, et al. Low mechanical index contrast-enhanced ultrasound better reflects high arterial perfusion of liver metastases than arterial phase computed tomography. Invest Radiology 2004;39:216.
21. Giorgio A, Ferraioli G, Tarantino L, et al. Contrast-enhanced sonographic appearance of hepatocellular carcinoma in patients with cirrhosis: comparison with contrast-enhanced helical CT appearance. AJR Am J Roentgenol 2004;183:1319.